Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.

Mol Oncol

Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada.

Published: October 2008

The tissue kallikrein (KLK) genes are a new source for biomarkers in ovarian cancer. However, there has been no systematic analysis of copy number and structural rearrangements related to their protein expression. Chromosomal rearrangements and copy number changes of the KLK region were studied by FISH with protein levels measured by ELISA. Ovarian cancer and cell lines revealed the KLK region was subject to copy number imbalances or involved in unbalanced translocations and were associated with increased protein expression of KLKs 5, 6, 7, 8, 9, 10 and 11. In this initial study, we introduce the potential for long-range chromosomal effects and copy number as a mechanism for the previously reported aberrant expression of many KLK genes in ovarian cancers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527811PMC
http://dx.doi.org/10.1016/j.molonc.2008.07.001DOI Listing

Publication Analysis

Top Keywords

copy number
16
ovarian cancer
12
klk genes
8
protein expression
8
klk region
8
impact cytogenetic
4
cytogenetic genomic
4
genomic aberrations
4
aberrations kallikrein
4
kallikrein locus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!